Article
Multiplexed single-cell transcriptomics reveals diverse phenotypic outcomes for pathogenic SHP2 variants.
Science advances - 22 May 2026
van Vlimmeren Anne E, Giglio Ross M, Jiang Ziyuan, Lee Minhee, McFaline-Figueroa José L, Shah Neel H
Abstract excerpt
The protein tyrosine phosphatase SHP2, encoded by PTPN11, is an important regulator of Ras/mitogen-activated protein kinase signaling that acts downstream of receptor tyrosine kinases and other transmembrane receptors. Germline PTPN11 mutations cause developmental disorders such as Noonan syndrome, whereas somatic mutations drive various cancers. While many pathogenic mutations enhance SHP2 catalytic activity,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
